Prevention and management strategies continue to evolve
Search results for: communication
Pearls for Preauthorization
Over the next several months, “From the College” will offer practical tips on improving office management guidelines, putting the latest healthcare information technology to work for you, and coding. This month, “From the College” offers some pearls for preauthorization.
Value-Driven Healthcare Moving Into Your Practice
In last month’s issue, “From the College” gave a brief overview of the theory of value-driven healthcare; in this month’s edition, we’ll move from the theory of value-driven healthcare to its implementation in today’s healthcare system.
Ortho Angle
Where rheumatology and orthopedics meet
Make a Difference by the End of Summer: Contact Congress
The more personal your contact with your elected officials, the more effective it will be. Although a personal discussion with a member of Congress is positive, a meeting or telephone conversation with one of his or her staff is just as valuable.
ARHP Angle: We Need a Few Good Leaders!
Flying back from Cincinnati, where I’d been attending a meeting of the ARHP Committee on Nominations, it occurred to me that some members might be intrigued by the process of how ARHP officers and committee and subcommittee chairs are selected. While I do realize that some members aren’t interested in the structural organization of ARHP, I know some may ask, “Why was she selected and not me?”
REMS Required
How will this FDA drug safety program affect rheumatology offices?
Tailor the Message for Arthritis Self-Care
Delving into patients’ perceptions of self-management activities
Identity Theft: Red Flag Rules Take Effect
The Federal Trade Commission (FTC) has adopted a rule that requires creditors to institute programs to spot suspicious activity (commonly called “red flags”) that may signal identity theft, and the red flag rules take effect May 1, 2009. The FTC defines a creditor as any entity that regularly accepts deferred payment for goods and services.
Drug Risk Versus Benefit
Perceptions from the FDA, physicians, and patients
- « Previous Page
- 1
- …
- 81
- 82
- 83
- 84
- 85
- …
- 89
- Next Page »